Norinchukin Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.6M | Buy |
395,023
+13,065
| +3% | +$1.08M | 0.37% | 41 |
|
|
2025
Q4 | $32.6M | Sell |
381,958
-136,553
| -26% | -$11.2M | 0.38% | 38 |
|
|
2025
Q3 | $40.3M | Buy |
518,511
+12,228
| +2% | +$955K | 0.54% | 30 |
|
|
2025
Q2 | $39.6M | Buy |
506,283
+12,920
| +3% | +$964K | 0.59% | 28 |
|
|
2025
Q1 | $35.8M | Buy |
493,363
+44,663
| +10% | +$3.2M | 0.66% | 28 |
|
|
2024
Q4 | $33.2M | Buy |
448,700
+6,593
| +1% | +$461K | 0.7% | 27 |
|
|
2024
Q3 | $29.2M | Buy |
442,107
+190,903
| +76% | +$13.9M | 0.69% | 29 |
|
|
2024
Q2 | $23.2M | Buy |
251,204
+14,033
| +6% | +$1.24M | 0.66% | 30 |
|
|
2024
Q1 | $22.7M | Sell |
237,171
-33,834
| -12% | -$2.84M | 0.68% | 30 |
|
|
2023
Q4 | $20.7M | Sell |
271,005
-138,026
| -34% | -$9.6M | 0.48% | 33 |
|
|
2023
Q3 | $28.3M | Buy |
409,031
+49,744
| +14% | +$4M | 0.67% | 26 |
|
|
2023
Q2 | $33.9M | Buy |
359,287
+116,908
| +48% | +$10.2M | 0.57% | 28 |
|
|
2023
Q1 | $20.1M | Buy |
+242,379
| New | +$19.1M | 0.4% | 41 |
|
|
2022
Q4 | – | Sell |
-47,652
| Closed | -$3.94M | – | 550 |
|
|
2022
Q3 | $3.94M | Buy |
47,652
+5,252
| +12% | +$505K | 0.08% | 155 |
|
|
2022
Q2 | $4.03M | Sell |
42,400
-15,517
| -27% | -$1.61M | 0.08% | 151 |
|
|
2022
Q1 | $6.82M | Buy |
57,917
+4,344
| +8% | +$487K | 0.09% | 132 |
|
|
2021
Q4 | $6.94M | Sell |
53,573
-257
| -0.5% | -$30K | 0.09% | 128 |
|
|
2021
Q3 | $6.09M | Buy |
53,830
+2,393
| +5% | +$273K | 0.08% | 134 |
|
|
2021
Q2 | $5.33M | Sell |
51,437
-464
| -0.9% | -$43.7K | 0.08% | 135 |
|
|
2021
Q1 | $4.34M | Buy |
51,901
+894
| +2% | +$75.6K | 0.06% | 147 |
|
|
2020
Q4 | $4.65M | Sell |
51,007
-1,148
| -2% | -$95.2K | 0.07% | 135 |
|
|
2020
Q3 | $4.16M | Buy |
52,155
+834
| +2% | +$65.1K | 0.07% | 137 |
|
|
2020
Q2 | $3.55M | Sell |
51,321
-1,041
| -2% | -$74K | 0.06% | 146 |
|
|
2020
Q1 | $3.29M | Sell |
52,362
-30,465
| -37% | -$2.2M | 0.06% | 140 |
|
|
2019
Q4 | $6.44M | Sell |
82,827
-7,536
| -8% | -$588K | 0.08% | 141 |
|
|
2019
Q3 | $6.62M | Buy |
90,363
+2,202
| +2% | +$155K | 0.09% | 142 |
|
|
2019
Q2 | $5.43M | Sell |
88,161
-30,156
| -25% | -$1.82M | 0.08% | 148 |
|
|
2019
Q1 | $7.55M | Buy |
118,317
+3,465
| +3% | +$198K | 0.1% | 143 |
|
|
2018
Q4 | $5.86M | Buy |
114,852
+34,056
| +42% | +$1.72M | 0.08% | 154 |
|
|
2018
Q3 | $4.69M | Buy |
80,796
+9,156
| +13% | +$448K | 0.06% | 158 |
|
|
2018
Q2 | $3.48M | Buy |
71,640
+13,908
| +24% | +$649K | 0.05% | 181 |
|
|
2018
Q1 | $2.69M | Buy |
57,732
+6,975
| +14% | +$303K | 0.04% | 191 |
|
|
2017
Q4 | $1.91M | Buy |
50,757
+3,606
| +8% | +$132K | 0.03% | 251 |
|
|
2017
Q3 | $1.72M | Buy |
47,151
+3,474
| +8% | +$132K | 0.03% | 284 |
|
|
2017
Q2 | $1.72M | Buy |
43,677
+2,250
| +5% | +$82.1K | 0.04% | 271 |
|
|
2017
Q1 | $1.3M | Buy |
41,427
+2,511
| +6% | +$78.6K | 0.03% | 303 |
|
|
2016
Q4 | $1.22M | Buy |
38,916
+4,725
| +14% | +$153K | 0.03% | 294 |
|
|
2016
Q3 | $1.37M | Buy |
34,191
+873
| +3% | +$32.9K | 0.03% | 270 |
|
|
2016
Q2 | $1.11M | Buy |
33,318
+279
| +0.8% | +$9.55K | 0.03% | 282 |
|
|
2016
Q1 | $971K | Buy |
33,039
+2,808
| +9% | +$77.5K | 0.02% | 310 |
|
|
2015
Q4 | $796K | Sell |
30,231
-6,675
| -18% | -$173K | 0.02% | 319 |
|
|
2015
Q3 | $874K | Buy |
36,906
+366
| +1% | +$8.83K | 0.02% | 334 |
|
|
2015
Q2 | $867K | Sell |
36,540
-1,818
| -5% | -$41K | 0.02% | 341 |
|
|
2015
Q1 | $911K | Sell |
38,358
-54,954
| -59% | -$1.23M | 0.02% | 345 |
|
|
2014
Q4 | $1.98M | Buy |
93,312
+53,052
| +132% | +$1.07M | 0.05% | 192 |
|
|
2014
Q3 | $685K | Buy |
40,260
+16,644
| +70% | +$263K | 0.02% | 270 |
|
|
2014
Q2 | $338K | Sell |
23,616
-3,012
| -11% | -$40.8K | 0.01% | 383 |
|
|
2014
Q1 | $329K | Buy |
26,628
+2,106
| +9% | +$24.3K | 0.01% | 408 |
|
|
2013
Q4 | $269K | Sell |
24,522
-780
| -3% | -$8.79K | 0.01% | 418 |
|
|
2013
Q3 | $294K | Buy |
25,302
+1,824
| +8% | +$21.3K | 0.01% | 394 |
|
|
2013
Q2 | $263K | Buy |
+23,478
| New | +$278K | 0.01% | 370 |
|
Other funds holding EW
VCM
VPM
Norinchukin Bank's EW Position: Q1 2026 in Review
Norinchukin Bank increased its Edwards Lifesciences (EW) stake by 3.4% in Q1 2026, buying an estimated $1.08M and bringing the position to 395,023 shares worth $31.6M. The position accounts for 0.37% of the portfolio, ranked #41.
Norinchukin Bank first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $40.3M in Q3 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Norinchukin Bank held 395,023 shares of Edwards Lifesciences worth $31.6M as of Q1 2026.
- Norinchukin Bank bought 13,065 Edwards Lifesciences shares in Q1 2026, an estimated $1.08M.
- Edwards Lifesciences made up 0.37% of Norinchukin Bank's portfolio in Q1 2026, its #41 holding.
- Norinchukin Bank first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- Norinchukin Bank's Edwards Lifesciences position peaked at $40.3M in Q3 2025.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Norinchukin Bank's 13F filing for Q1 2026, filed 15 May 2026.